Summary. The immature rat ovary contains VIP immunoreactive nerve fibres sparsely distributed around blood vessels, in the interstitial gland and around follicles. The VIP concentration, measured radioimmunologically, decreased significantly after PMSG treatment (10 i.u.), probably due to ovarian enlargement and oedema, while the total VIP content (total of 0\m=.\12 pmol in both ovaries) did not change after PMSG priming. The ovulatory effect of VIP was studied using in-vitro perfused ovaries from immature 28-day-old rats primed with 10i.u. PMSG. In all ovaries perfused, VIP (10\m=-\7m) induced ovulations with a rate of 2\m=.\33\ m=+-\ 0\m=.\56. The ovulation rate was significantly lower than that of ovaries stimulated by LH (0\m=.\1\g=m\g/ml)(5\m=.\20 \m=+-\0\m=.\86ovulations per ovary). No synergistic effect on the ovulation rate was seen when LH and VIP were administered together (5\m=.\20\ m=+-\ 0\m=.\49ovulations per ovary). The results suggest that the neuropeptide VIP may represent one of the local factors involved in the ovulation process.
Introduction
Vasoactive intestinal polypeptide (VIP) is a 28-amino acid peptide located in central and peripheral nerves where it appears to function as a neurotransmitter (Hökfelt et ai, 1984; Hansen et ai, 1986) . VIP-containing nerves innervate many different tissues, thus having a wide variety of actions, including vasodilatation, smooth muscle relaxation in the respiratory, gastrointestinal and urogeni¬ tal tracts, hormone release from pancreas and facilitatory effects on secretion from salivary glands. The VIP immunoreactive nerve fibres reach the ovary via the suspensory ligament (Dees et ai, 1986) and are located around blood vessels, in the interstitial gland and in the follicular wall ofthe ovary (Kannisto et ai, 1986; Ahmed et ai, 1986) . The existence of VIP mRNA in the rat ovary also suggests a local synthesis of VIP in the gland (Gozes & Tsafriri, 1986) .
The fact that VIP influences smooth muscle cells in the follicular wall (Schmidt et ai, 1988a) , ovarian steroid production (Fredericks et ai, 1983; Davoren & Hsueh, 1985; Ahmed et ai, 1986; Ottesen et ai, 1986) and plasminogen activator activity in rat granulosa cells and cumulus-oocyte complexes (Liu et ai, 1987) indicates that VIP may be involved in the ovulatory process. VIP immunoreactive fibres have been demonstrated in the hypothalamus and the anterior pituitary and there is reason to believe that VIP is involved in the regulation of prolactin secretion (Kato et ai, 1978; Ottesen et ai, 1981) . To study the direct effect of VIP at the ovarian level, thus avoiding systemic effects ofthe peptide, a well established in-vitro perfusion system for the PMSG-primed immature rat ovary was used (Koos et ai, 1984; Schmidt et ai, 1986 (1977) . The sensitivity ofthe assay was 3-3 pmol/1; intra-and interassay coefficients of variations were approximately 10 and 15%, respectively. Samples (1-5 ml) from the perfusion medium were withdrawn in some exper¬ iments for VIP analysis. The samples were stored at -18°C before radioimmunological determination of VIP as described in detail by Helm et ai (1987) . The sensitivity ofthe assay was 3-8pmol/l; intra-and interassay variations were 4% and 8-5% respectively.
In-vitro perfusion. The surgical procedure and preparation of the ovaries have been described in detail elsewhere (Koos et ai, 1984) . The rats (28 animals) were anaesthetized with pentobarbitone sodium (40 mg/kg body wt i.p.; Mebumal: ACO, Solna, Sweden). After injection of 100 IU heparin (Heparin sodium: Kabi Vitrum, Stockholm, Sweden) into a tail vein the abdomen was opened. The abdominal part of the aorta and vena cava were cannulated with infusion catheters (Viggo, Helsingborg, Sweden) and were dissected free together with the right ovary and its ovarian artery and vein. The preparation was then removed and connected to the perfusion apparatus.
The recirculating perfusion system is thoroughly described and has been used in several experiments in our labora¬ tory (Schmidt et ai, 1985 (Schmidt et ai, , 1986 (Schmidt et ai, , 1988b . Three ovaries were perfused simultaneously in three identical perfusion systems. The medum was M 199 with Earle's salts and L-glutamine (Gibco Bio-Cult, Paisley, UK). Bicarbonate (0-026 m) was added to obtain a pH of 7-4 when the medium was continuously oxygenated with a gas mixture of 5% C02 and 95% 02. The medium also contained 75 pg benzylpenicillin G/ml, 50 pg streptomycin/ml, 0-2 IU heparin/ ml, 002 IU insulin/ml and 2% fatty acid-free bovine serum albumin (BSA, Sigma). The perfusion medium was maintained at 37°C and the pressure was adjusted to 70-90 mmHg, giving a flow ofthe perfusate of about 0-8 ml/min. 
Results
Presence of VIP on the rat ovary
The distribution of VIP immunoreactivity is illustrated in Figs 1 and 2 . Ovaries from the untreated immature rats contained a sparse number of VIP fibres running in the proximity of blood vessels as well as in the ovarian stroma and around follicles. In ovaries from the PMSG-primed rats excised in the evening of Day 28 (19:00-20:00 h) hardly any VIP fibres were observed.
As shown in Table I , ovaries from PMSG-primed rats ofthe same age as controls and killed at 08:00-10:00 h were more than twice as heavy. The ovarian weight of PMSG-treated rats increased still more in the evening (19:00-20:00 h) and in the following morning (04:00-05:00 h). The VIP concentration (Table 1) was significantly higher in the untreated group when compared with the PMSG-treated groups. The total VIP content in both ovaries (pmol) ( Table 1) showed only minor, statistically non-significant, variations between groups.
Ovaries perfused in vitro
No significant changes in flow rate and perfusion pressure were observed after the addition of any of the substances to the perfusion medium. An oedematous swelling of the ovary was noticed with the stereomicroscope as well as with the naked eye within 3 h of the LH and VIP adminis¬ tration. No ovulation was seen during the first 9 h of perfusion. Some of the oocytes recovered in the morning were degenerated.
No ovulations occurred in the control group perfused with saline alone ( of VIP fibres in the ovary have been reported by others (Larssonera/., 1977; Hâkanson et ai, 1982; Kannisto et ai, 1986; Ahmed et ai, 1986) and indicates that VIP may have an influence on ovarian function. There was a sparse number of VIP fibres in the ovary compared to other organs in the female genital tract (Helm et ai, 1981; Ahmed et ai, 1986; Kannisto et ai, 1986; Owman & Stjernquist, 1988) , and ovarian enlargement after PMSG treatment is probably the reason why no VIP nerves could be discovered in ovaries from the PMSG-primed rats. A depletion of VIP from nerve fibres and ovarian tissue is unlikely since the total ovarian VIP content did not decrease after PMSG treatment. PMSG is able to induce a synchronized development of a first generation of preovulatory follicles with a subsequent endogenous gonadotrophin surge leading to ovulation (Ekholm et ai, 1981 (Ekholm et ai, , 1982 . The extraction method used in this study has been evaluated to be at least as effective as the more commonly used 'boiled water-acetic acid' method (Fahrenkrug et ai, 1978) . Accordingly, the ovarian VIP concentration was ofthe same magnitude or somewhat higher than reported earlier (Ottesen et ai, 1981; Huang et ai, 1984; Ahmed et ai, 1986) and did not change significantly before and after the LH surge or after ovulation.
Ovaries were perfused with two different concentrations of the neuropeptide: 10~9m-VIP corresponds well with basal plasma levels (for references, see Ottesen, 1983) , while 10"7 m-VIP is known to cause certain biological effects in vitro (Ottesen, 1983; Ojeda et ai, 1989) . All glassware was siliconized and the tubing was made of Teflon, Viton and silicone to reduce adsorption of steroids and other substances during perfusion (for further details see Janson et ai, 1982) . How¬ ever, VIP determinations on the perfusion medium showed a decrease in VIP concentration during perfusion, probably due to a certain degree of adsorption and metabolization of the peptide (Ahmed et ai, 1986) . The VIP dose was therefore repeated after 8 h of perfusion.
In the present study VIP alone induced ovulation in the in-vitro perfusion system. The ovu¬ latory effect was dose-dependent, the higher dose (10~7m) causing approximately 45% of the ruptures induced by LH. The ovulations were probably due to the presence ofthe peptide since no follicle ruptures occurred in the perfused control ovaries (see also Koos et ai, 1984; Schmidt et ai, 1986 Schmidt et ai, , 1988b . No synergistic effects on the ovulation rate were seen when LH was present together with VIP in the perfusion medium. This is in accordance with results from in-vivo experiments with rabbits by Fredericks et ai (1983) . Intravenous infusion of VIP in the rabbit during oestrus or öfter ovulation induction with human chorionic gonadotrophin (hCG) increased progesterone secretion, but no effect was seen upon fertility or the number of corpora lutea formed. There are several ways in which VIP may have a direct ovarian influence on the ovulatory process. Within 3 h of perfusion, ovaries treated with LH or VIP showed an oedematous swelling while control ovaries maintained approximately their original size. The vascular changes occurring in the ovary and especially in the mature follicles after the LH surge include vasodilatation and increased permeability of the capillaries, leading to extravasation of serum proteins, increasing interstitial oedema and, hence, a greater availability of hormones and other circulating agents to the ovary. The appearance of fenestrations and intercellular gaps between adjacent endothelial cells (Okuda et ai, 1983) as ovulation approaches makes a free connection between the capillary lumen and the follicu¬ lar antrum possible (Bjersing & Cajander, 1974) . These changes and the invasion of leucocytes, basophils and platelets around mature follicles has been compared to an inflammatory reaction (Espey, 1980) . Many vasoactive substances such as histamine, 5-hydroxytryptamine and prostaglan¬ dins can take part in this event (Espey, 1980; Schmidt et ai, 1988b, c) . The vasodilatory action of VIP (Said, 1980) and the presence of VIP-containing nerves around arterioles in the ovary, as docu¬ mented in this study and reported by others (Larsson et ai, 1977; Helm et ai, 1981; Ahmed et ai, 1986) , will probably contribute to the preovulatory ovarian hyperaemia. VIP-containing nerves also innervate the theca externa ofthe follicular wall (Ahmed et ai, 1986; Kannisto et ai, 1986) . The neuromuscular complex ofthe follicle wall (Burden, 1978; Owman et ai, 1979) is suggested as being involved in the ovulatory process (Owman et ai, 1979) . VIP may influence the follicle wall indirectly by modifying the nerve-mediated effect on the smooth muscle cells in the theca externa (Misbahuddin et ai, 1986; Yau et ai, 1986) or by a direct relaxant action on the cells (Schmidt et ai, 1988a) .
VIP is also known to stimulate ovarian steroid secretion in the rabbit (Fredericks et ai, 1983) and rat (Davoren & Hsueh, 1985; Ahmed et ai, 1986) , with cAMP as one of the intracellular messengers (Davoren & Hsueh, 1985; Törnell et ai, 1988) . Progesterone has been shown to induce ovulation in hypophysectomized rats (Takahashi et ai, 1974) as well as in explanted hamster ovaries in vitro (Baranczuk & Fainstat, 1976) , and it facilitates ovulation in incubated rabbit follicles (Testart et ai, 1983) and in rabbit ovaries perfused in vitro (Holmes et ai, 1985) . Forskolin, an activator of adenylate cyclase, is able to induce ovulation in the rabbit ovary perfused in vitro (Holmes et ai, 1986) , and in the perfused rat ovary both forskolin and cAMP induce ovulation (Brännström et ai, 1987) . VIP also stimulates plasminogen activator activity in granulosa cells and cumulus-oocyte complexes in the rat (Liu et ai, 1987) . Since plasminogen activator activity, with generation of proteolytic enzymes, is involved in the ovulatory process (Akazawa et ai, 1983; Reich et ai, 1985) , it is possible that this is yet another way whereby VIP contributes to the process of ovulation. 
